quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:00·1366d
PRRelease
Innoviva Inc. logo
La Jolla Pharmaceutical Company logo
Royalty Pharma plc logo

Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

INVA· Innoviva Inc.LJPC· La Jolla Pharmaceutical CompanyRPRX· Royalty Pharma plc
Health Care
Original source

Companies

  • INVA
    Innoviva Inc.
    Health Care
  • LJPC
    La Jolla Pharmaceutical Company
    Health Care
  • RPRX
    Royalty Pharma plc
    Health Care

Recent analyst ratings

  • Feb 17INVAUpdateBTIG Research$35.00
  • Jan 30RPRXUpdateUBS$49.00
  • Sep 30RPRXUpdateGoldman$42.00
  • Sep 30INVAUpdateGoldman$17.00
  • Aug 11INVAUpdateOppenheimer$45.00
  • Jul 14INVAUpdateH.C. Wainwright$40.00

Related

  • PR2d
    Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
  • PR7d
    Royalty Pharma Declares Second Quarter 2026 Dividend
  • PR8d
    Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
  • SEC10d
    SEC Form 8-K filed by Royalty Pharma plc
  • SEC13d
    SEC Form DEFA14A filed by Royalty Pharma plc
  • SEC13d
    SEC Form DEF 14A filed by Royalty Pharma plc
  • INSIDER21d
    SEC Form 4 filed by Coyne Terrance P.
  • SEC22d
    SEC Form 13F-NT filed by Royalty Pharma plc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022